![](/img/cover-not-exists.png)
Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β 2 -Agonist Combined With a Long-Acting Muscarinic or Inhaled Corticosteroid
Samp, Jennifer C., Joo, Min J., Schumock, Glen T., Calip, Gregory S., Pickard, A. Simon, Lee, Todd A.Language:
english
Journal:
Annals of Pharmacotherapy
DOI:
10.1177/1060028017719716
Date:
July, 2017
File:
PDF, 586 KB
english, 2017